Article Details
Retrieved on: 2023-12-18 17:50:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
DUBLIN, Dec. 18, 2023 /PRNewswire/ -- Theravance Biopharma, Inc.(Theravance Biopharma or the Company) (NASDAQ: TBPH ) today announced that.
Article found on: menafn.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here